A Phase I Study of MGAH22 in Patients With Refractory HER2 Positive Cancers

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT01195935
First received: September 3, 2010
Last updated: August 7, 2014
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Estimated Primary Completion Date: No date given